FOS and esophageal cancer: Overall, our results in esophageal cancer cells treated with HOI-02 suggest that ROS activate AP-1 and cleaved caspase 3, which contribute to apoptosis, and also p21 signaling, which participates in G2-M arrest (Figure 6c).